Recombinant human serum albumin (OsrHSA) has emerged as a big innovation in the field of biopharmaceuticals, supplying promising developments across many clinical and industrial purposes. With its structural similarity to Normally derived human serum albumin, OsrHSA presents a safer, a lot more responsible substitute for therapeutic use, specifical